New video from NORD and C-Path addresses the question: “What is a Registry?”
Written by Laura Mullen on June 2, 2020
What is a registry and why are they so important to the rare disease community? Together, NORD and the Critical Path Institute (C-Path) created this video to explain the value in registries… Read More
Innovative Data and Analytics Platform to Accelerate Drug Development for Rare Diseases
Written by Laura Mullen on September 19, 2019
Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.
TUCSON, Ariz. and WASHINGTON, September 19, 2019 — The Critical Path Institute… Read More
FUNDED BY FDA, C-PATH and NORD TO LAUNCH RARE DISEASE DATA ANALYTICS PLATFORM
Written by Lisa Sencen on August 7, 2019
The collaborative project between the organizations will kick off at a launch meeting in September and will aim to reduce barriers for the development of new treatments and cures for rare diseases.
TUCSON, Ariz. and WASHINGTON,